HIGHLIGHTS
- What: Precision targeted therapy has always been one of the important goals of drug research, and the emergence of mAb technology has provided a good technical means to achieve this goal.
- Who: Cancer, therapy and Ziming, Zhao from the RCF experimental school, Beijing, China have published the paper: New progress in cancer treatment based on monoclonal antibodies, in the : Proceedings of the 4th International Conference on Biological Engineering and Medical Science
- Future: The rise of individualized treatment allows the authors to formulate precise treatment plans based on the specific tumor characteristics of patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.